Detecting predictive androgen receptor modifications in circulating prostate cancer cells-Reference-Cited by-同舟云学术

Detecting predictive androgen receptor modifications in circulating prostate cancer cells

Published:2015-04-23 Issue:41 Volume:10 Page:4213-4223
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Steinestel Julie¹²,Luedeke Manuel¹,Arndt Annette³,Schnoeller Thomas J.¹,Lennerz Jochen K.⁴,Wurm Carina¹,Maier Christiane¹,Cronauer Marcus V.¹,Steinestel Konrad⁵,Schrader Andres J.¹²

Affiliation:

1. Clinic of Urology, University Hospital Ulm, Ulm, Germany

2. Clinic of Urology, University Hospital Muenster, Muenster, Germany

3. Institute of Pathology and Molecular Pathology, Bundeswehrkrankenhaus Ulm, Ulm, Germany

4. Massachusetts General Hospital/Harvard Medical School, Boston, MA, USA

5. Gerhard-Domagk Institute of Pathology, University of Muenster, Muenster, Germany

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 93 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molekulare Tumorboards in der Uroonkologie – Prostatakarzinom;Die Urologie;2024-08-06

2. Detecting androgen receptor (AR), AR variant 7 (AR-V7), prostate-specific membrane antigen (PSMA), and prostate-specific antigen (PSA) gene expression in CTCs and plasma exosome-derived cfRNA in patients with metastatic castration-resistant prostate cancer (mCRPC) by integrating the VTX-1 CTC isolation system with the QIAGEN AdnaTest;BMC Cancer;2024-04-16

3. How to Integrate Prostate Cancer Biomarkers in Urology Clinical Practice: An Update;Cancers;2024-01-11

4. Longitudinal assessment of plasma androgen receptor copy number predicts overall survival in subsequent treatment lines in castration-resistant prostate cancer: analysis from a prospective trial;ESMO Open;2023-12

5. Genomic and Phenotypic Biomarkers for Precision Medicine Guidance in Advanced Prostate Cancer;Current Treatment Options in Oncology;2023-08-10